Description

ZISAVEL 100 MG (1X7)

Indications

ZISAVEL 100 MG is primarily indicated for the treatment of various allergic conditions, including allergic rhinitis, urticaria, and other allergic skin disorders. It is effective in alleviating symptoms such as sneezing, runny nose, itchy or watery eyes, and skin rashes. The medication is suitable for adults and children over the age of six, providing relief from both seasonal and perennial allergies.

Mechanism of Action

ZISAVEL contains the active ingredient Levocetirizine, which is an antihistamine. It works by selectively inhibiting peripheral H1 receptors, thereby blocking the action of histamine, a substance in the body that causes allergic symptoms. By preventing histamine from binding to its receptors, ZISAVEL reduces the physiological responses associated with allergic reactions, including vasodilation, increased vascular permeability, and stimulation of sensory nerves.

Pharmacological Properties

The pharmacokinetics of Levocetirizine reveal that it is rapidly absorbed after oral administration, with peak plasma concentrations occurring approximately 1 hour after dosing. The bioavailability of Levocetirizine is approximately 100%, and it has a half-life of about 8 to 10 hours, allowing for once-daily dosing. The drug is primarily excreted through the kidneys, with about 85% of the dose eliminated as unchanged drug in urine. This pharmacological profile makes ZISAVEL an effective option for managing allergic symptoms with minimal dosing frequency.

Contraindications

ZISAVEL is contraindicated in patients with a known hypersensitivity to Levocetirizine or any of its components. Additionally, it should not be used in individuals with severe renal impairment or end-stage renal disease, as the drug is primarily eliminated through the kidneys. Caution is advised in patients with a history of urinary retention or bladder obstruction, as antihistamines may exacerbate these conditions.

Side Effects

Common side effects associated with ZISAVEL include drowsiness, fatigue, dry mouth, and gastrointestinal disturbances such as nausea. Less frequently, patients may experience dizziness, headache, or allergic reactions such as rash or pruritus. It is important for patients to be aware of these potential side effects and to consult their healthcare provider if they experience any severe or persistent symptoms.

Dosage and Administration

The recommended dosage of ZISAVEL for adults and children over the age of 12 is 5 mg once daily. For children aged 6 to 11 years, the recommended dosage is 2.5 mg once daily. It is advised to take the medication in the evening to minimize the impact of drowsiness during waking hours. ZISAVEL can be taken with or without food, and the tablets should be swallowed whole with water. Patients with renal impairment may require dosage adjustments based on their level of kidney function.

Interactions

Levocetirizine may interact with other medications, particularly those that cause sedation, such as benzodiazepines, opioids, and other central nervous system depressants. Concurrent use of these medications can enhance the sedative effects of ZISAVEL, increasing the risk of drowsiness and impaired motor function. It is important for patients to inform their healthcare provider of all medications they are currently taking to avoid potential interactions.

Precautions

Patients should exercise caution when using ZISAVEL if they have a history of epilepsy or seizures, as antihistamines may lower the seizure threshold. Additionally, individuals with liver impairment should be monitored closely, as the metabolism and clearance of Levocetirizine may be affected. Patients are advised to avoid alcohol while taking ZISAVEL, as it can exacerbate drowsiness and impair cognitive function. Pregnant or breastfeeding women should consult their healthcare provider before using this medication to weigh the risks and benefits.

Clinical Studies

Clinical studies have demonstrated the efficacy of ZISAVEL in reducing allergic symptoms. In a randomized, double-blind, placebo-controlled trial involving patients with allergic rhinitis, those treated with Levocetirizine showed significant improvement in nasal and ocular symptoms compared to the placebo group. Another study focusing on chronic urticaria found that patients receiving Levocetirizine experienced a marked reduction in itch severity and wheal size. These studies support the use of ZISAVEL as an effective treatment option for managing allergic conditions.

Conclusion

ZISAVEL 100 MG is a well-tolerated and effective antihistamine for the management of allergic symptoms. Its rapid onset of action, once-daily dosing, and favorable safety profile make it a suitable choice for patients suffering from allergic rhinitis and other allergic disorders. As with any medication, it is essential for patients to follow their healthcare provider’s recommendations and to be aware of potential side effects and interactions.